Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection
نویسندگان
چکیده
منابع مشابه
Recent advances in pharmacological neuroprotection
Treatment of brain ischaemic remains a challenging issue. During the last decade there has been much interest in the development of drugs with signifi cant neuroprotective effects against ischaemic injury in stroke patients. However, clinical trials have been disappointing as, so far, they all have failed to provide evidence for neuroprotection. Several reasons including lack of convincing expe...
متن کاملPharmacological cardioprotection in diabetes
Acute coronary syndrome (ACS) in patients with diabetes continues to present clinical management challenges despite recent improvements in the management of ACS. The diabetic myocardium is more vulnerable to ischemia–reperfusion injury than non-diabetic myocardium and the diabetic patient more likely to develop complications, significant morbidity and death following ACS. Currently, ACS managem...
متن کاملPharmacological and Non-Pharmacological Recanalization Strategies in Acute Ischemic Stroke
According to the guidelines of the European Stroke Organization (ESO) and the American Stroke Association (ASA), acute stroke patients should be managed at stroke units that include well organized pre- and in-hospital care. In ischemic stroke the restoration of blood flow has to occur within a limited time window that is accomplished by fibrinolytic therapy. Newer generation thrombolytic agents...
متن کاملRecent advances in the pathophysiology and pharmacological treatment of obesity.
WHAT IS KNOWN AND OBJECTIVE The increasing prevalence of obesity and associated morbidity present unmet medical needs for safe and effective new drug therapies. Our aim is to review the diverse targets and compounds that are in clinical development. METHODS Literature searches were conducted using the PUBMED database for studies published in English from January 1985 to December 2011 using co...
متن کاملPharmacological topics of bone metabolism: recent advances in pharmacological management of osteoporosis.
The prevention of osteoporotic fracture is an essential socioeconomical priority, especially in the developed countries including Japan. Estrogen, selective estrogen-receptor modulators (SERMs), and bisphosphonate are potent inhibitors of bone resorption; and they have clinical relevance to reduce osteoporotic fractures in postmenopausal women. However, we can prevent at most 50% of vertebral f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Molecular Sciences
سال: 2019
ISSN: 1422-0067
DOI: 10.3390/ijms20164002